about
sameAs
P1889
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BAnti-tumor activity of a miR-199-dependent oncolytic adenovirusmiR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.MicroRNA involvement in hepatocellular carcinoma.MicroRNA response to environmental mutagens in liver.p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries.Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients
P50
Q24564757-16A0B255-15A7-4DB5-A8CC-8E831574E9C3Q27307206-92321E58-9E38-4BE3-BCBD-CC224A547331Q34248579-C5C02A02-60B5-4154-8021-A8B04E813687Q34675280-5CB6CD10-40DC-4AD9-97F9-2CD24A74A191Q37262433-92877C83-A47D-4FDE-B804-F8021A6AFD0FQ37361575-A39FE67D-4793-42BB-8DDE-98A1605EB7EAQ37868183-BBC31DD3-80BE-4C93-A652-B96DAFC5B2F1Q39044964-8E7811C3-A055-4803-BF37-E1949C0DB5D7Q39817084-81C36285-7561-419E-8BF6-732E49E521B3Q40066973-F7DD841B-6D33-4CF1-AE68-E0538CFC30E6Q40218147-D80C2EF4-5132-4E99-A29E-BA35042382B0Q40241153-357B935B-371D-43AA-9F69-5C2E0475D1DCQ45408352-783B4C11-D6DB-403A-93CB-9C22161EC8DCQ51542616-72A72F6D-6AA7-4B0F-A379-BA05A9D19A1EQ54519450-7D916BCA-DC30-46B3-97C6-E4790C3D9242Q61014579-BF300BA0-093A-416E-B8D9-4BAFC79510A8
P50
description
(1977-) Dottorato di ricerca in biochimica, biologia molecolare e biotecnologie
@it
(1977-)
@es
(1977-)
@pt
sceintist, born 1977
@en
wetenschapper
@nl
name
Elisa Callegari
@ast
Elisa Callegari
@en
Elisa Callegari
@es
Elisa Callegari
@it
Elisa Callegari
@nl
Elisa Callegari
@pt
Elisa Callegari
@sl
type
label
Elisa Callegari
@ast
Elisa Callegari
@en
Elisa Callegari
@es
Elisa Callegari
@it
Elisa Callegari
@nl
Elisa Callegari
@pt
Elisa Callegari
@sl
prefLabel
Elisa Callegari
@ast
Elisa Callegari
@en
Elisa Callegari
@es
Elisa Callegari
@it
Elisa Callegari
@nl
Elisa Callegari
@pt
Elisa Callegari
@sl
P101
P214
P1053
J-5763-2016
P106
P1153
8603707900
P1889
P21
P214
P31
P3829
P396
IT\ICCU\CFIV\260894
P496
0000-0002-4969-5400
P512
P569
1977-07-15T00:00:00Z